Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cryofocus Medtech specializes in minimally invasive interventional cryotherapy medical devices. It has commercialized products for atrial fibrillation and bladder cancer, with additional systems for hypertension, asthma, COPD, airway stenosis, gastric and esophageal cancers at various clinical or regulatory stages. The company’s AF Cryoablation System received NMPA approval. Its pipeline includes the world’s first dedicated cryoablation device targeting hypertension via renal denervation—currently in late-stage trials—with further respiratory intervention products advancing through confirmatory trials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cryofocus Medtech.